Tracking structural changes in preclinical and prodromal Alzheimer’s disease: insights from amyloid‐beta pathology

Abstract

Background: Amyloid‐beta (Aβ) and tau pathology in Alzheimer’s disease (AD) is commonly associated with disruptions in grey matter integrity, including reduced cortical thickness (CT) and increased cortical mean diffusivity (MD).

The paper